Cargando…
Mathematical model of hormone sensitive prostate cancer treatment using leuprolide: A small step towards personalization
In this paper we present a new version of a mathematical model of Elishmereni et al. describing androgen deprivation therapy (ADT) for hormone sensitive prostate cancer patients (HSPC). We first focus on the detail description of the model, and then we present mathematical analysis of the proposed m...
Autores principales: | Foryś, Urszula, Nahshony, Alon, Elishmereni, Moran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846544/ https://www.ncbi.nlm.nih.gov/pubmed/35167616 http://dx.doi.org/10.1371/journal.pone.0263648 |
Ejemplares similares
-
Predicting Outcomes of Prostate Cancer Immunotherapy by Personalized Mathematical Models
por: Kronik, Natalie, et al.
Publicado: (2010) -
Effectiveness of three different luteinizing hormone-releasing hormone agonists in the chemical castration of patients with prostate cancer: Goserelin versus triptorelin versus leuprolide
por: Shim, Myungsun, et al.
Publicado: (2019) -
Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
por: Wallach, Joshua D., et al.
Publicado: (2021) -
Response to Degarelix After Resistance to Leuprolide in a Patient With Metastatic Prostate Cancer
por: Lazenby, Mark
Publicado: (2012) -
Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
por: Neely, E. Kirk, et al.
Publicado: (2010)